Actinium Pharmaceuticals, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
AMEX
Actinium Pharmaceuticals CEO Sandesh Seth will dispose of 120,900 shares of common stock on August 18, 2025, to cover tax obligations from RSU vesting.
AMEX
Richard I. Steinhart, a director at Actinium Pharmaceuticals, canceled several stock options effective March 31, 2025.
AMEX
Jeffrey W. Chell, a director at Actinium Pharmaceuticals, canceled several stock options on March 31, 2025, as per an Option Cancellation and Release Agreement.
AMEX
Director June Sherie Almenoff cancels stock options to purchase 50,000 shares of Actinium Pharmaceuticals common stock effective March 31, 2025.
AMEX
C. David Nicholson, a director at Actinium Pharmaceuticals, canceled several stock options effective March 31, 2025.
AMEX
Director Ajit Shetty cancels multiple stock options in Actinium Pharmaceuticals, effective March 31, 2025, as per an Option Cancellation and Release Agreement.
AMEX
Actinium Pharmaceuticals CEO, Sandesh Seth, cancels multiple stock options effective March 31, 2025, as per an Option Cancellation and Release Agreement.
AMEX
Chief Financial Officer Steve O'Loughlin cancels multiple stock options at Actinium Pharmaceuticals effective March 31, 2025.
AMEX
June Almenoff, a director of Actinium Pharmaceuticals, was granted stock options to purchase 50,000 shares of common stock.